XAIR – Beyond Air Inc
Beyond Air, Inc.XAIR
$2.49Name : Beyond Air, Inc.
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $4,147,050.00
EPSttm : -64.4
Beyond Air, Inc.
$2.49
1.24%$0.031
XAIR — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
4.2
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
Price
2.52
Target Price
18.33
Analyst Recom
1
Performance Q
-58.02
Upside
-35,153.9%
Beta
0.29
Ticker: XAIR
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-10-12 | XAIR | 2.32 | N/A | N/A | 0 |
| 2026-10-13 | XAIR | 2.16 | N/A | N/A | 0 |
| 2026-10-14 | XAIR | 2.05 | N/A | N/A | 0 |
| 2026-10-15 | XAIR | 2.23 | N/A | N/A | 0 |
| 2026-10-16 | XAIR | 2.2599 | N/A | N/A | 0 |
| 2026-10-19 | XAIR | 2.18 | N/A | N/A | 0 |
| 2026-10-20 | XAIR | 2.2 | N/A | N/A | 0 |
| 2026-10-21 | XAIR | 2.32 | N/A | N/A | 0 |
| 2026-10-22 | XAIR | 2.21 | N/A | N/A | 0 |
| 2026-10-23 | XAIR | 2.14 | N/A | N/A | 0 |
| 2026-10-26 | XAIR | 2.19 | N/A | N/A | 0 |
| 2026-10-27 | XAIR | 2.17 | N/A | N/A | 0 |
| 2026-10-28 | XAIR | 2.3301 | N/A | N/A | 0 |
| 2026-10-29 | XAIR | 2.31 | N/A | N/A | 0 |
| 2026-10-30 | XAIR | 2.25 | N/A | N/A | 0 |
| 2026-11-02 | XAIR | 2.21 | N/A | N/A | 0 |
| 2026-11-03 | XAIR | 2.26 | N/A | N/A | 0 |
| 2026-11-04 | XAIR | 2.35 | N/A | N/A | 0 |
| 2026-11-05 | XAIR | 2.18 | N/A | N/A | 0 |
| 2026-11-06 | XAIR | 2.15 | N/A | N/A | 0 |
| 2026-11-09 | XAIR | 2.24 | N/A | N/A | 0 |
| 2026-11-10 | XAIR | 2.595 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-10-12 | XAIR | 2.36 | - | - | - |
| 2026-10-13 | XAIR | 2.20 | - | - | - |
| 2026-10-14 | XAIR | 2.05 | - | - | - |
| 2026-10-15 | XAIR | 2.24 | - | - | - |
| 2026-10-16 | XAIR | 2.16 | - | - | - |
| 2026-10-19 | XAIR | 2.13 | - | - | - |
| 2026-10-20 | XAIR | 2.13 | - | - | - |
| 2026-10-21 | XAIR | 2.19 | - | - | - |
| 2026-10-22 | XAIR | 2.24 | - | - | - |
| 2026-10-23 | XAIR | 2.09 | - | - | - |
| 2026-10-26 | XAIR | 2.23 | - | - | - |
| 2026-10-27 | XAIR | 2.22 | - | - | - |
| 2026-10-28 | XAIR | 2.34 | - | - | - |
| 2026-10-29 | XAIR | 2.30 | - | - | - |
| 2026-10-30 | XAIR | 2.28 | - | - | - |
| 2026-11-02 | XAIR | 2.21 | - | - | - |
| 2026-11-03 | XAIR | 2.24 | - | - | - |
| 2026-11-04 | XAIR | 2.35 | - | - | - |
| 2026-11-05 | XAIR | 2.18 | - | - | - |
| 2026-11-06 | XAIR | 2.16 | - | - | - |
| 2026-11-09 | XAIR | 2.27 | - | - | - |
| 2026-11-10 | XAIR | 2.52 | - | - | - |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-10-12 | XAIR | 69.44 | -1.36 | 7.47 |
| 2026-10-13 | XAIR | 69.44 | -1.36 | 7.47 |
| 2026-10-14 | XAIR | 74.22 | -1.36 | 7.47 |
| 2026-10-15 | XAIR | 74.22 | -1.36 | 7.47 |
| 2026-10-16 | XAIR | 74.30 | -1.36 | 7.47 |
| 2026-10-19 | XAIR | 75.06 | -1.54 | 7.47 |
| 2026-10-20 | XAIR | 75.06 | -1.54 | 7.47 |
| 2026-10-21 | XAIR | 74.58 | -1.54 | 7.47 |
| 2026-10-22 | XAIR | 72.02 | -1.54 | 7.47 |
| 2026-10-23 | XAIR | 72.44 | -1.54 | 7.47 |
| 2026-10-26 | XAIR | 72.82 | 2.69 | 7.47 |
| 2026-10-27 | XAIR | 33.02 | 2.69 | 0 |
| 2026-10-28 | XAIR | 33.02 | 2.69 | 4.20 |
| 2026-10-29 | XAIR | 32.97 | 2.69 | 4.20 |
| 2026-10-30 | XAIR | 32.97 | 2.69 | 4.20 |
| 2026-11-02 | XAIR | 32.97 | 2.67 | 4.20 |
| 2026-11-03 | XAIR | 32.97 | 2.67 | 4.20 |
| 2026-11-05 | XAIR | 33.01 | 2.67 | 4.20 |
| 2026-11-06 | XAIR | 32.97 | 2.67 | 4.20 |
| 2026-11-09 | XAIR | 32.93 | 0.02 | 4.20 |
| 2026-11-10 | XAIR | 32.93 | 0.02 | 4.20 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-3.3
Avg. EPS Est. Next Quarter
-2.23
Insider Transactions
32.93
Institutional Transactions
0.02
Beta
0.29
Average Sales Estimate Current Quarter
2
Average Sales Estimate Next Quarter
2
Fair Value
Quality Score
20
Growth Score
48
Sentiment Score
48
Actual DrawDown %
100
Max Drawdown 5-Year %
-100
Target Price
18.33
P/E
Forward P/E
PEG
P/S
0.55
P/B
0.95
P/Free Cash Flow
EPS
-68.49
Average EPS Est. Cur. Y
EPS Next Y. (Est.)
-25
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-435.71
Relative Volume
0.25
Return on Equity vs Sector %
-100
Return on Equity vs Industry %
-100
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
◆
XAIR
Healthcare
$2.54
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
53.5
Range 1M
100%
Sup Dist
14.6%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
0%
EPS NY
0%
52W%
1%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+621.7% upside
Upside
+621.7%
Quality
20
XAIR — P/E HistoricalMedical Devices
Beyond Air, Inc.Sector: Healthcare
Industry: Medical Devices
Employees: 54
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO to treat viral lung infections, such as viral community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM). In addition, the company develops ultra-high concentration NO (UNO) that is in Phase 1 clinical trial to treat solid tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.
XAIR
Latest News
—
Caricamento notizie per XAIR…
stock quote shares XAIR – Beyond Air Inc Stock Price stock today
news today XAIR – Beyond Air Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch XAIR – Beyond Air Inc yahoo finance google finance
stock history XAIR – Beyond Air Inc invest stock market
stock prices XAIR premarket after hours
ticker XAIR fair value insiders trading